相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pre-incubation of corneal donor tissue with sCD83 improves graft survival via the induction of alternatively activated macrophages and tolerogenic dendritic cells
Katrin Peckert-Maier et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2022)
The role of medicinal products in the treatment of inflammatory bowel diseases (IBD) through inhibition ofTLR4/NF-kappaBpathway
Pegah Dejban et al.
PHYTOTHERAPY RESEARCH (2021)
Inducing immune tolerance with dendritic cell-targeting nanomedicines
Anna Cifuentes-Rius et al.
NATURE NANOTECHNOLOGY (2021)
Co-stimulation with opposing macrophage polarization cues leads to orthogonal secretion programs in individual cells
Andres R. Munoz-Rojas et al.
NATURE COMMUNICATIONS (2021)
Soluble CD83 Regulates Dendritic Cell-T Cell Immunological Synapse Formation by Disrupting Rab1a-Mediated F-Actin Rearrangement
Wei Lin et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Epithelial cell-derived CD83 restores immune tolerance in the airway mucosa by inducing regulatory T-cell differentiation
Li-Hua Mo et al.
IMMUNOLOGY (2021)
Soluble CD83 inhibits acute rejection by up regulating TGF-β and IDO secretion in rat liver transplantation
Liangxing Xiong et al.
TRANSPLANT IMMUNOLOGY (2021)
Targeting Immune Cell Trafficking - Insights From Research Models and Implications for Future IBD Therapy
Maximilian Wiendl et al.
FRONTIERS IN IMMUNOLOGY (2021)
Intestinal Epithelial Cell-Derived CD83 Contributes to Regulatory T-Cell Generation and Inhibition of Food Allergy
Yong Yu et al.
JOURNAL OF INNATE IMMUNITY (2021)
Herpes Simplex Virus Type-2 Paralyzes the Function of Monocyte-Derived Dendritic Cells
Linda Grosche et al.
VIRUSES-BASEL (2020)
Endogenous CD83 Expression in CD4+ Conventional T Cells Controls Inflammatory Immune Responses
Katarina Liedtke et al.
JOURNAL OF IMMUNOLOGY (2020)
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
Birgit Sawitzki et al.
LANCET (2020)
The CD83 Molecule - An Important Immune Checkpoint
Linda Grosche et al.
FRONTIERS IN IMMUNOLOGY (2020)
Neutrophil heterogeneity and fate in inflamed tissues: implications for the resolution of inflammation
Janos G. Filep et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2020)
CD83, a Novel MAPK Signaling Pathway Interactor, Determines Ovarian Cancer Cell Fate
Aalia Batool et al.
CANCERS (2020)
Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
Waka Yokoyama-Kokuryo et al.
ARTHRITIS RESEARCH & THERAPY (2020)
CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes
Moritz Rapp et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Mediators of the Resolution of the Inflammatory Response
Michelle A. Sugimoto et al.
TRENDS IN IMMUNOLOGY (2019)
Resident Macrophages Cloak Tissue Microlesions to Prevent Neutrophil-Driven Inflammatory Damage
Stefan Uderhardt et al.
CELL (2019)
The role of macrophages in the resolution of inflammation
Satoshi Watanabe et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Soluble CD83: a proresolving mediator in inflammatory arthritis?
Jessica McHugh
NATURE REVIEWS RHEUMATOLOGY (2019)
The Evolving Roles of Macrophages in Organ Transplantation
Junhui Li et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2019)
Endogenous Expression of the Human CD83 Attenuates EAE Symptoms in Humanized Transgenic Mice and Increases the Activity of Regulatory T Cells
Elisabeth Zinser et al.
FRONTIERS IN IMMUNOLOGY (2019)
CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential
Ziduo Li et al.
FRONTIERS IN IMMUNOLOGY (2019)
Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner
Dmytro Royzman et al.
FRONTIERS IN IMMUNOLOGY (2019)
The Membrane-Associated MARCH E3 Ligase Family: Emerging Roles in Immune Regulation
Heng Lin et al.
FRONTIERS IN IMMUNOLOGY (2019)
Resolution of inflammation during multiple sclerosis
F. Ruiz et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Resolution of inflammation in arthritis
Georg Schett
SEMINARS IN IMMUNOPATHOLOGY (2019)
MHC class II fine tuning by ubiquitination: lesson from MARCHs
Satoshi Ishido et al.
IMMUNOGENETICS (2019)
CD83 orchestrates immunity toward self and non-self in dendritic cells
Andreas B. Wild et al.
JCI INSIGHT (2019)
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
Ziduo Li et al.
HAEMATOLOGICA (2018)
MARCH1 protects the lipid raft and tetraspanin web from MHCII proteotoxicity in dendritic cells
Jaehak Oh et al.
JOURNAL OF CELL BIOLOGY (2018)
The levels of soluble forms of CD21 and CD83 in multiple sclerosis
Sajad Karampoor et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
Neutrophils induce macrophage anti-inflammatory reprogramming by suppressing NF-κB activation
John A. Marwick et al.
CELL DEATH & DISEASE (2018)
CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma
Ziduo Li et al.
HAEMATOLOGICA (2018)
Soluble CD83 Alleviates Experimental Autoimmune Uveitis by Inhibiting Filamentous Actin-Dependent Calcium Release in Dendritic Cells
Wei Lin et al.
FRONTIERS IN IMMUNOLOGY (2018)
Macrophages in inflammation, repair and regeneration
Yumiko Oishi et al.
INTERNATIONAL IMMUNOLOGY (2018)
Resolution of chronic inflammatory disease: universal and tissue-specific concepts
Georg Schett et al.
NATURE COMMUNICATIONS (2018)
CD83 expression is essential for Treg cell differentiation and stability
Marina Doebbeler et al.
JCI INSIGHT (2018)
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches
Rita Diehl et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes
Joe M. Horvatinovich et al.
JOURNAL OF IMMUNOLOGY (2017)
Current and emerging therapeutic targets for IBD
Markus F. Neurath
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis
Wei Lin et al.
SCIENTIFIC REPORTS (2017)
The Major Immediate-Early Protein IE2 of Human Cytomegalovirus Is Sufficient to Induce Proteasomal Degradation of CD83 on Mature Dendritic Cells
Christiane S. Heilingloh et al.
Frontiers in Microbiology (2017)
Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83
Julia von Rohrscheidt et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection
Haiyin Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population
Xinsheng Ju et al.
JOURNAL OF IMMUNOLOGY (2016)
CD83 Modulates B Cell Activation and Germinal Center Responses
Lena Krzyzak et al.
JOURNAL OF IMMUNOLOGY (2016)
Resolution of inflammation: a new therapeutic frontier
James N. Fullerton et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
The role of neutrophils in inflammation resolution
Hefin R. Jones et al.
SEMINARS IN IMMUNOLOGY (2016)
Resolution of inflammation: what Controls its Onset?
Michelle A. Sugimoto et al.
FRONTIERS IN IMMUNOLOGY (2016)
Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo
Simon Kreiser et al.
IMMUNOBIOLOGY (2015)
Continuous expression of CD83 on activated human CD4+ T cells is correlated with their differentiation into induced regulatory T cells
Liwen Chen et al.
MOLECULAR MEDICINE REPORTS (2015)
Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis
J. M. Bates et al.
MUCOSAL IMMUNOLOGY (2015)
UniProt: a hub for protein information
Alex Bateman et al.
NUCLEIC ACIDS RESEARCH (2015)
Inflammatory triggers of acute rejection of organ allografts
Daniel N. Mori et al.
IMMUNOLOGICAL REVIEWS (2014)
Loss of MHC II ubiquitination inhibits the activation and differentiation of CD4 T cells
Rikiya Ishikawa et al.
INTERNATIONAL IMMUNOLOGY (2014)
Herpes simplex virus type 1 ICP0 induces CD83 degradation in mature dendritic cells independent of its E3 ubiquitin ligase function
Christiane S. Heilingloh et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Soluble CD83 ameliorates experimental colitis in mice
J. Eckhardt et al.
MUCOSAL IMMUNOLOGY (2014)
T Cell Costimulation Molecules CD80/86 Inhibit Osteoclast Differentiation by Inducing the IDO/Tryptophan Pathway
Aline Bozec et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Indoleamine 2,3 dioxygenase in intestinal disease
Matthew A. Ciorba
CURRENT OPINION IN GASTROENTEROLOGY (2013)
Resolution of inflammation: an integrated view
Almudena Ortega-Gomez et al.
EMBO MOLECULAR MEDICINE (2013)
Soluble human CD83 ameliorates lupus in NZB/W F1 mice
Charlotte Starke et al.
IMMUNOBIOLOGY (2013)
Topical Application of Soluble CD83 Induces IDO-Mediated Immune Modulation, Increases Foxp3+ T Cells, and Prolongs Allogeneic Corneal Graft Survival
Felix Bock et al.
JOURNAL OF IMMUNOLOGY (2013)
Different Partners, Opposite Outcomes: A New Perspective of the Immunobiology of Indoleamine 2,3-Dioxygenase
Ciriana Orabona et al.
MOLECULAR MEDICINE (2012)
CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation
Lina E. Tze et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2
Liwen Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction
Gianluca Matteoli et al.
GUT (2010)
Induction of Kidney Allograft Tolerance by Soluble CD83 Associated With Prevalence of Tolerogenic Dendritic Cells and Indoleamine 2,3-Dioxygenase
Zhu Lan et al.
TRANSPLANTATION (2010)
Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection
Wei Ge et al.
TRANSPLANTATION (2010)
Prevention of Chronic Renal Allograft Rejection by Soluble CD83
Zhu Lan et al.
TRANSPLANTATION (2010)
Kruppel-like Factor KLF10 Targets Transforming Growth Factor-β1 to Regulate CD4+CD25- T Cells and T Regulatory Cells
Zhuoxiao Cao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia
B. D. Hock et al.
LEUKEMIA RESEARCH (2009)
CD83 on murine APC does not function as a costimulatory receptor for T cells
Birte Kretschmer et al.
IMMUNOLOGY LETTERS (2008)
CD83 expression in CD4+ T cells modulates inflammation and autoimmunity
Simone Reinwald et al.
JOURNAL OF IMMUNOLOGY (2008)
CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages
Machteld M. Tiemessen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo
Charlene M. Prazma et al.
JOURNAL OF IMMUNOLOGY (2007)
CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells
Yoshihiro Kuwano et al.
INTERNATIONAL IMMUNOLOGY (2007)
A limited course of soluble CD83 delays acute cellular rejection of MHC-mismatched mouse skin allografts
Jun-Fa Xu et al.
TRANSPLANT INTERNATIONAL (2007)
Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients
BD Hock et al.
TISSUE ANTIGENS (2006)
Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation
D Dudziak et al.
JOURNAL OF IMMUNOLOGY (2005)
CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells
WP Cao et al.
BIOCHEMICAL JOURNAL (2005)
The soluble form of CD83 is present at elevated levels in a number of hematological malignancies
BD Hock et al.
LEUKEMIA RESEARCH (2004)
A novel mutation in CD83 results in the development of a unique population of CD4+ T cells
LF García-Martínez et al.
JOURNAL OF IMMUNOLOGY (2004)
Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83
E Zinser et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The soluble form of CD83 dramatically changes the cytoskeleton of dendritic cells
N Kotzor et al.
IMMUNOBIOLOGY (2004)
CD83 expression influences CD4+ T cell development in the thymus
Y Fujimoto et al.
CELL (2002)
The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells
M Lechmann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera
BD Hock et al.
INTERNATIONAL IMMUNOLOGY (2001)
Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells
SO Cramer et al.
INTERNATIONAL IMMUNOLOGY (2000)
分享论文
